Search results
Have $3,000? Buying These 2 Phenomenal Growth Stocks in 2024 Would Be a Genius Move.
Motley Fool via Yahoo Finance· 2 hours agoThe Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. *Stock Advisor...
3 No-Brainer Warren Buffett Stocks to Buy Right Now
Motley Fool via Yahoo Finance· 2 hours ago3% during the same period. Put another way, Visa is more efficient at turning revenue...Visa trades at a lower P/E ratio than Mastercard, making its ...
3 Speculative Penny Stocks That Can Spike to Double Digits in 2024
InvestorPlace· 6 days agoPenny stocks can surprise. While speculative activity in these stocks is high, the ideas are backed...
These 3 High-Yield Dividend Stocks Are Set to Soar in 2024 and Beyond
Motley Fool via Yahoo Finance· 2 days agoStock Advisor service has more than quadrupled the return of S&P 500 since 2002*. *Stock Advisor...
3 New Reasons to Like This Magnificent Dividend Stock
Motley Fool via Yahoo Finance· 1 day ago3. Price and outlook P&G's stock is valued at about the middle of the range that investors have seen...
Marshawn Kneeland NFL Draft 2024: Scouting Report for Dallas Cowboys Edge
Bleacher Report· 11 hours agoHEIGHT: 6'3" WEIGHT: 267 HAND: 9⅛⅛" ARM: 34½½" WINGSPAN: 83⅜⅜" 40-YARD DASH: 4.75 3-CONE: 7.02...
JinkoSolar (NYSE:JKS) Stock Rating Lowered by StockNews.com
ETF DAILY NEWS· 9 hours agoDaiwa Capital Markets downgraded shares of JinkoSolar from an “outperform” rating to a “neutral” rating and set a $25.00 price target on the stock. UBS ...
Zura Bio Limited (NASDAQ:ZURA) EVP Kiran Nistala Acquires 3,195 Shares of Stock
ETF DAILY NEWS· 2 days agoZura Bio Limited (NASDAQ:ZURA – Get Free Report) EVP Kiran Nistala bought 3,195 shares of the company’s stock in a transaction on Monday, April 22nd. The ...
2024 NFL Draft: Fantasy football winners and losers after Rounds 2 and 3
Yahoo Sports· 7 hours agoBut this could easily set up as a thunder-and-lightning situation, with both players having games...
Corcept Therapeutics (NASDAQ:CORT) Stock Rating Upgraded by StockNews.com
ETF DAILY NEWS· 9 hours agoSeveral other research analysts have also commented on the company. HC Wainwright reiterated a “buy” rating and set a $38.00 price target on shares of Corcept Therapeutics ...